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Abstract: Diabetic Retinopathy (DR) is one of the main causes of blindness and visual impairment in 
developed countries, stemming solely from diabetes mellitus. Current screening methods using fundus 
images rely on the experience of the operator as they are manually examined. Automated methods based 
on neural networks and other approaches have not provided sensitivity or specificity above 85%. This 
work presents a computer vision based method that directly identifies hard exudates and dot 
haemorrhages (DH) from 100 digital fundus images from a graded database of images using standard 
computer vision techniques, and clinical observation and knowledge. Sensitivity and specificity in 
diagnosis are 95-100% in both cases. Positive and negative prediction values (PPV, NPV) were 95-100% 
for both cases. The overall method is general, computationally efficient and suitable for further clinical 
trials to test both accuracy and the ability to the track DR status over time. 
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1. INTRODUCTION 
Diabetic Retinopathy (DR) is one of the main causes of 
blindness and visual impairment in developed countries (Icks 
et al, 1997; Fong et al, 2004). The prevalence of retinopathy 
and vision threatening retinopathy in the US are 40.3% and 
8.2% respectively for diabetic adults 40 years or older 
(TEDPRG, 2004). The number of people with diabetes is 
expected to double in the next 15-30 years due to obesity, 
aging populations and inactive lifestyles, with over 80% of 
diabetic individuals affected by DR (Wild et al, 2004). 
However, early detection combined with appropriate 
treatment and management can prevent the loss of vision in 
up to 95% of cases (Fong et al, 2003, 2004; Chia et al, 2004; 
ETDRSRG, 1991).  
The high prevalence of diabetes therefore makes mass 
screening an expensive and time consuming process. An 
automated system could greatly reduce the workload by 
filtering out 50% of the screening population (Hipwell et al, 
2000). However, a recent 11,000 patient study concluded that 
automated detection of diabetic retinopathy using published 
algorithms cannot yet be recommended for clinical practice 
(Abramoff et al, 2008), indicating a significant need for 
improvement in this arena.  
DR results from leakage of small vessels in the retina due to 
hyperglycaemia. In the early stages, known as non-
proliferated retinopathy, there may be haemorrhages due to 
bleeding of the capillaries, or exudates resulting from protein 
deposits in the retina. There is usually no vision loss unless 
there is a build up of fluid in the centre of the eye. As the 
disease progresses, new abnormal vessels grow in the retina, 
known as neovascularisation. These vessels frequently leak 
into the vitreous, which is called proliferated retinopathy and 
may cause severe visual problems. The goal of screening is to 
detect non-proliferated DR to implement management that 
decreases the chances of (long-term) vision impairment. 
The use of seven-field stereo fundus photography read by a 
trained reader is the gold standard diagnostic. DR grading 
using the fundus images is significantly more sensitive than 
standard opthalmoscopy, which can miss approximately 50% 
of subjects with only microaneurysms, resulting in under 
reporting of DR by ~10 % (Kinyoun et al, 1992; Moss et al, 
1985). Recent research has combined fundus photography 
and computer algorithms to grade DR (Abramoff et al, 2008). 
The algorithms search for bad lesions in the fundus images 
which define the severity of DR. The lesions are categorised 
into microaneurysms, haemorrhages and exudates based on 
their location, morphology and colour. Several recent reports 
on detecting one of these lesion types report sensitivities of 
81.3-90.1% with false positive rates of ~18% (Sanchez et al, 
2007; Walter  et al, 2007; Sinthnayothin et al, 2002). The 
high false positive rates are the main issue with current 
computer vision based screening methods. The most common 
classifiers used with computer vision are neural networks or 
statistical classifiers (Frame et al, 1998; Gardner et al, 1996). 
This paper takes an alternative more analytical approach by 
focusing on direct identification using accurate geometric 
models at the preprocessing stage. Two separate algorithms 
are developed to detect exudates and dot haemorrhages. 
Information from the colour, morphology and intensity 
gradients of the fundus photographs provide a means to 
detect the number of exudates and dot haemorrhages and thus 
determine the presence of DR. This paper therefore focuses 
on the problem of accurately detecting DR rather than the 
grading of images. However, the methods presented are 
general enough to enable monitoring of the patients DR status 
over time given suitable images. Thus, computer vision may 
offer more than the current clinical, manual approach. 
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2. METHODS 
Two separate algorithms are written. One each for 
automatically detecting exudates and dot haemorrhages from 
fundus images. 
2.1 Identifying Hard Exudates: 
Exudates are common abnormalities in the retina, and are 
bright lipid leaked from a blood vessel. The leaked fluid 
tends to stay close to the puncture yielding a generally well-
defined edge suitable for computer analysis (Ege et al, 2000). 
Figure 1 gives an example of exudates on a fundus image, 
which show up as small, light yellow regions. However the 
optic disc, which can be seen in Figure 1, is also a light 
yellow region.   
Therefore, before searching for exudates, an algorithm is 
developed for automatic detection of the optic disc. In the 
image, the yellow colour corresponds to a high intensity on 
the green channel and typically the optic disc contains the 
majority of the highest green intensities on a given image.  
Thus, an initial approximation to the optic disc is obtained by 
sorting the green intensities from the lowest to the highest, 
and choosing all pixels in the top 0.5% of intensities. This 
method may also capture some other bright yellow regions 
like exudates, but the majority will lie on the optic disc.  
Figure 1 shows the optic disk identified as the largest 
connected region (LCR) of such dots on this color channel, as 
well as the bounding circle created to eliminate it from 
further consideration in the algorithm. 
 
Figure 1: Optic disk, LCR and hard exudates identified on a 
fundus image via yellow color. The LCR is identified in blue 
and doesn’t cover the entire optic disk, but the identified 
portion that is not searched as a result is circled. 
In identifying the other exudates in Figure 1, or any image, 
each region found must be bound by a contour to identify if it 
is 1 large exudate or several smaller exudates. Such contours 
would thus help identify, over time, the growth of current 
exudates and the number of any new exudates. 
The neighbourhood of an exudate is defined as a rectangle 
with a boundary 40 pixels from the unique rectangle precisely 
surrounding the exudate. Within the exudate neighbourhood, 
contours of red/green (R/G) intensity are computed around 
the mean R/G of the exudate. Contours of sufficient length 
and “nearby” are selected as potential exudates. Nearby is 
defined on the distance from the centre of the unique circle, 
with radius rEXUDATE precisely surrounding the exudate. 
Specifically, if any part of the contour is within a radius of 
1.5*rEXUDATE the contour is selected as a candidate for the 
boundary of exudate. Once all the “nearby” contours are 
selected, the contour with the largest mean absolute image 
gradient is chosen. In addition, the contour must have a 
length of greater than 20 pixels to be large enough for 
consideration. 
The overall algorithm is based on specific colour channels 
and standard image processing techniques in a new 
configuration. The algorithm is defined: 
 
I. Define Optic Disk: 
• Obtain top 0.5% of pixel intensities in green channel 
• Place a rectangle around the largest connected region 
• Define a circle with the centre at the left edge mid-point 
and radius of the horizontal width respectively 
• Increase radius 50% to guarantee disk is bounded 
II. Find Exudates Using Median Filter: 
• Compute 50 pixel median filter along all vertical and 
horizontal lines. Median filter takes the moving median 
intensity value over 50 pixels (centered). 
• Subtract the minimum of the median in each direction. 
From each pixel intensity to equalize the contrast over 
the image. 
• For each vertical and horizontal line, select pixels with 
filtered intensities > 10 and take the union. If the filtered 
intensities>30 and the green intensity >100, label the 
pixel ICE, where CE= “confirmed exudate”. 
• Form connected regions, remove regions with number of 
pixels < 5.  Remove regions containing pixels with red + 
green + blue channel < 60, remove regions containing 
pixels in optic disc. 
III. Add Pixels and Confirm Bright Exudates 
• For each exudate compute the lower 5th percentile Ilow 
and upper 95th percentile Ihigh of red/green (R/G) 
intensities.  Within a ± 100 pixel neighbourhood of the 
exudate, select pixels where: (R/G) ε [Ilow, Ihigh].  Add the 
selected pixels to the potential exudate if they are 
connected to the exudate. 
• Save all connected regions that have pixels labelled ICE.  
Remove these regions from the image analysis as they 
are confirmed as exudates. 
IV. Remove False Exudates: 
• In a 40-pixel neighbourhood of each remaining potential 
exudate, compute the R/G contours in steps of 0.05 ± 0.5 
around the mean R/G for the exudate. 
• Let rEXUDATE denote the radius of the unique circle, C, 
that precisely surrounds the exudate. Select a contour if:   
  a) Any part of contour is within 1.5*rEXUDATE  from  
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       the centre of the circle 
  b) The contour has a length > 20 pixels 
• For each selected contour, C, calculate the mean absolute 
gradient of the surrounding points and choose the 
contour corresponding to the largest value 
• Compute the distance Dc between the current contour 
and nearest exudate.  If Dc >4 pixels, reject the exudate 
V. Output Number and Size of All Exudates: 
2.2 Identifying Dot Haemorrhages: 
Haemorrhages are a secondary sign of diabetic retinopathy 
resulting from ruptured micro aneurysms, capillaries and 
venules. Classification of dot haemorrhages (DHs) depends 
on their location within the retinal layers. DHs are located 
within the outer plexiform and inner nuclear layer. The round 
shape and distinct borders of DHs are due to intra-retinal 
compression confining the DH to a specific location. 
DHs have a similar red colour to the vessels and are close to 
circular with well defined boundaries. This circularity is used 
to segment the DHs from other features in the fundus image. 
The colour similarity between DHs and vessels, makes it 
necessary to accurately detect the vessels from the image 
before checking for DHs. 
The ratio of the red to green (R/G) intensities gives the best 
definition of the red features, and is also more resistant to 
lighting changes between images. The R/G ratio brightens the 
vessels, DHs and the fovea, which are predominantly red, and 
dulls the primarily yellow optic disk and exudates. An 
example image of the R/G ratio is shown in Figure 2, where 
the significant brightening of the DH and vessels simplifies 
the choice of thresholds to select the desired regions. 
 
Figure 2: R/G intensities and identified DH, fovea and blood 
vessels, which are clearly shown in this transformed image. 
As with the exudate identification algorithm, the overall DH 
identification algorithm uses standard computer vision 
techniques in a new configuration, along with clinical 
observation or knowledge.  
The overall algorithm is defined: 
I. Create Binary Image: 
• Calculate R/G intensities from the fundus image 
• Apply 50 pixel median filter scaling to R/G intensities. 
• Threshold top 7% R/G intensities to yield binary image. 
II. Select Potential DHs by Shape: 
• Number all connected regions in binary image. 
• For each connected region calculate the shape factor Fs = 
A / Lmax, where A = area in pixels and Lmax = maximum 
distance between any 2 pixels in the region. 
• Label all regions with 30 or more pixels and a shape 
factor greater than 0.54 as potential DH’s. 
III. Check if Potential DHs are Blood Vessels: 
• For each potential DH find the line of minimum distance 
to the largest neighbouring connected region.   
• Calculate the difference in intensity between the 
maximum and minimum intensities along the line of 
minimum distance. 
• If difference between maximum and minimum intensities 
< 0.5, the potential DH is unlabeled and connected to 
neighbouring region. 
IV. Remove False DHs: 
• In a 40-pixel neighbourhood of each remaining DH, 
compute the R/G contours in steps of 0.05 ± 0.5 around 
the mean R/G for the DH. 
• Let rDH denote the radius of the unique circle Ccircle 
precisely surrounding the DH. Select a contour if:   
             a) Any part of contour is within 1.5* rDH from the  
                  centre of the circle 
              b) The contour has a length > 20 pixels 
• For each selected contour, calculate the mean absolute 
gradient of the surrounding points and choose the 
contour C corresponding to the largest value. 
• Compute the distance Dc between the current contour 
and nearest DH.  If Dc >4 pixels, reject the DH. 
V. Output Number and Size of All DHs: 
 
2.3 Analysis and Testing: 
The algorithms were developed base on fundus images from 
the DiaretdbO_v_1_1 database (Kauppi et al, 2006, 2007). 
Comparison is made to manual counting and identification of 
both DHs and exudates in each image. Results are measured 
in terms of: Specificity, Sensitivity, Positive Predictive Value 
(PPV) and Negative Predictive Value (NPV). All threshold 
values, such as filtered intensities, the number of pixels to 
form connected intensities, and the shape factor from the 
algorithm were determined from a selection of 6 images, 
three which were difficult images to diagnose and three that 
were straightforward. Accounting for the worst case 
scenarios that are selected by eye, avoids having to train the 
algorithms on excessive numbers of images. 
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Diagnoses for these tests are based on existence, which only 
captures whether (or not) of these phenomena are present. 
Thus, R0 and M0 diagnoses indicate the existence of one or 
more DHs (R0) or exudates (M0). The absence of DHs and 
exudates are diagnosed R1 and M1, respectively. Thus, if the 
images are considered as being sequential over time, they 
would also diagnose the occurrence (or not) of new exudates 
and/or DHs, highlighting changes in the patient’s DR status. 
 
3. RESULTS AND DISCUSSION 
3.1 Hard Exudate Identification: 
The algorithm detected the presence of exudates correctly 
according to the diagnosis of (Kauppi et al, 2006, 2007) in all 
but two cases.  The results are summarized in Table 1, with a 
sensitivity of 94.9% and specificity of 96.7%. Note that to the 
human eye, the two false positives appeared to be exudates 
and the fact that dot haemorrhages are also present confirms 
this possibility. However, the images were pronounced clear 
by the diagnosis in (Kauppi et al, 2006, 2007). Similar 
results/controversy occurred for the two false negatives, 
demonstrating the inherent subjectivity involved in DR 
screening. Thus, no computer algorithm should be expected 
to fully agree with every ophthalmologist’s observation in 
these types of cases, but do provide a consistent measure 
without subjectivity. 
Figure 3: Image 099 (M1) showing false positives found 
when algorithm is used without Step IV. 
 
Table 1: Hard exudate identification results 
 Observed Diagnosis  
 M1 M0  
M1 59 2 PPV  0.97 
M0 2 37 NPV  0.95 
 
Specificity 
96.7% 
Sensitivity 
94.9% 
 
 
One of the reasons for the significant accuracy of the method 
is the use of the contour method to remove false exudates. 
The contour method is based a little on the concept of level 
set methods to find closed boundaries in an image. A level set 
method evolves level 0 contours by solving a partial 
differential equation (PDE) until the object contour settles 
around the object or shape of interest. The stopping criteria is 
usually a region of high gradient. The contour method 
assumes that the image intensity contour surface already 
contains the required boundary around the shape of interest. 
This approach thus avoids having to solve a PDE which is 
very computationally expensive and not suitable for this 
application. The solution to the PDE is effectively the image 
intensity surface. To extract the final contour, the contour 
with essentially the largest gradient is chosen as detailed in 
the algorithms of the methodology. To the authors’ 
knowledge this is a new approach in image processing which 
shows particular promise for DR.  
Figure 3 shows the value of the contour checker in Step IV of 
the exudate algorithm, where an image (#099) is diagnosed 
M1 or clear of exudates. The figure shows several identified 
regions along blood vessels where image contrast would have 
yielded false positive results without this added algorithm 
step. Note that simply eliminating all exudates within a 
tolerance of a blood vessel is not an effective solution, as 
exudates can lie close to veins and would be falsely removed. 
However, with the contour method, if an exudate is close to a 
vein the contour surrounds the exudate and thus does not 
remove it. Alternatively, around a false exudate the contour 
method finds the boundary of the vein, and pixels along this 
located boundary lie far away from the false exudate, leading 
to its removal in  Step IV. 
To demonstrate the overall efficacy of the algorithm, Figures 
4 shows two images. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Specific before-after images of exudate 
identification algorithm results. 
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The first is a standard fundus image and the second shows the 
identified hard exudates pixellated over top. It is clear that 
while they are easily found by eye with experience, they are 
not readily found at first glance. These marks match the 
results and diagnosis in the database. 
More specifically, Figure 4 shows the original image in 
Figure 4a without processing and the identified image 
automatically generated from the algorithm. The 3 exudates 
are circled and pixellated in yellow in Figure 4b after 
processing. Clinically, these three exudates are of significant 
size and would likely be considered as readily identifiable to 
a skilled or experienced technician. 
Finally, speed and computational time are important. Each 
image in the 100 image database was processed with this 
algorithm in approximately 40-80 seconds. Each image had 2 
Mpixels of data, where current fundus images can be much 
larger if required. However, the algorithm was also not 
optimised for speed. Thus a 1 minute, on average, processing 
time occurs. With optimisation or the use of C instead of 
Matlab, this time would be on the order of 1-10 seconds. 
Clinically, such turnaround times would enable the images to 
be taken and answer provided to the clinician, and expressed 
to the patient, in real-time while still in the office. 
 
3.2 DH Identification: 
For the first 100 from the DIARETDB0 database (Kauppi et 
al, 2006, 2007), the DH algorithm detected the presence of 
DHs accurately with no false positives and one false 
negative, as seen in Table 2. Again, the baseline for diagnosis 
was determined from the database and associated works. 
 
Table 2: DH identification results. 
 Observed Diagnosis  
 R1 R0  
R1 1 24 PPV  96.0% 
R0 75 0 NPV  100% 
 
Sensitivity  
98.7% 
Specificity 
100% 
 
 
The algorithm failed to correctly diagnose 1 image, which 
contained a DH as seen in Figure 5. However, the DH is seen 
to lie in a dark region of this particular image, as shown by 
the labelled section “C”. As the DH lies in this dark region, 
the boundaries are not well defined. Therefore, when the 
fundus photograph is converted into a binary image, the 
shape of the DH becomes distorted and the shape factor, Fs, 
equation in Step II of the DH algorithm rules this DH out. 
Without the contour checker, the algorithm found 5 false 
positives instead of 1. But in a similar way to the case of the 
exudates, the contour method easily removed these false 
points. On the other hand, the contour method presently only 
works on regions that have been identified. Thus, it does not 
eliminate the false negative. However, simulations have 
shown that the contour method does not exclude these 
regions that were missed by the algorithm. Thus, future work 
should include the contour method in the initial identification 
part of the algorithm. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Close view of false negative (C is missed, but 
found in the database) with recurring almost perfectly round 
spots not identified here or in (Kauppi et al, 2006, 2007). 
 
Note that although there appears to be more than one DH in 
Figure 5, the recurring dark spots are not DH. These dark 
dots appear in almost all of the images in the database at the 
exact same location and are assumed to be associated with 
dust on the camera lens or similar imperfection. Other 
databases do not have such spots on their images, but also did 
not have diagnoses associated with their images. Hence, this 
image database was still used. Overall, these spots are 
ignored when processing the results of the algorithm. In 
practice, the quality of the lens could be checked, for 
example, by taking a picture of a white page. 
 
4. CONCLUSIONS 
Automatic methods for screening exudates and dot 
haemorrhages have been developed based on image 
processing methods that utilize colour, morphology and 
intensity gradients in fundus photographs. 100 images from a 
standard database were used to test the methods. For exudate 
detection, the sensitivity was 96.9% and specificity was 
94.9% in terms of whether detecting the presence of DR or 
not. For dot haemorrhages, the sensitivity was 98.7% due to 
one false negative and the specificity was 100 %. From visual 
checks of the images, there were virtually no false exudates 
or dot haemorrhages detected which suggests the method 
could be used to accurately track changes over time. 
However, these results need to be validated in future clinical 
trials. 
The reasons for the very high sensitivity with no false 
positives are the use of the red/ green ratio combined with a 
contour finding method and the image gradient after median 
filtering. The red/ green ratio has the advantages of helping to 
C 
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normalize out changes in light across the images and 
improves the contrast of DR features relative to the 
background. Furthermore, no statistical classifying methods 
were required.  
The methods demonstrate a significant improvement over 
other algorithms in the literature and show potential for 
practical, clinical DR screening. The use of colour channels 
to directly identify DR dysfunctions allows clinical expertise 
and observation to be directly incorporated into the 
algorithm, providing a potentially far superior result.  
Finally, it is also obvious that further clinical testing and 
trials will be required to prove the algorithm in practice. 
However, the same approach can be taken to a wider range of 
dysfunction or disease in the eye. Additionally, the ability to 
detect the number and size implies further clinical outcomes 
will be available in terms of tracking or monitoring patient 
evolution. 
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